Regeneron Pharmaceuticals
Regeneron is seeking a Bench Scientist to join its Ophthalmology group, supporting the development of therapeutics for ocular and autoimmune diseases. The role involves designing and performing in vitro and in vivo studies, developing new assays, and evaluating therapeutic candidates to advance discovery efforts. This position offers the opportunity to contribute to a science-driven organization making a meaningful difference to patients worldwide.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
58% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Research Specialist D
University of Pennsylvania
Scientist II, Cellular Immunology
AbbVie
In Vivo Pharmacology Scientist
Amgen
Associate Scientist – Cell-Based Assays & In Vivo Oncology
Aragen Life Sciences
Principal Associate Scientist
Xaira Therapeutics
Associate Scientist, In vivo Pharmacology, Inflammation
lifelancer